000 | 01937 a2200493 4500 | ||
---|---|---|---|
005 | 20250517155734.0 | ||
264 | 0 | _c20180827 | |
008 | 201808s 0 0 eng d | ||
022 | _a1433-2965 | ||
024 | 7 |
_a10.1007/s00198-017-4090-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGifre, L | |
245 | 0 | 0 |
_aEffect of recent spinal cord injury on the OPG/RANKL system and its relationship with bone loss and the response to denosumab therapy. _h[electronic resource] |
260 |
_bOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _c09 2017 |
||
300 |
_a2707-2715 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aBiomarkers _xblood |
650 | 0 | 4 |
_aBone Density _xdrug effects |
650 | 0 | 4 |
_aBone Density Conservation Agents _xpharmacology |
650 | 0 | 4 |
_aBone Remodeling _xdrug effects |
650 | 0 | 4 |
_aDenosumab _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aOsteoporosis _xblood |
650 | 0 | 4 |
_aOsteoprotegerin _xblood |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aRANK Ligand _xblood |
650 | 0 | 4 |
_aSpinal Cord Injuries _xblood |
650 | 0 | 4 | _aYoung Adult |
700 | 1 | _aRuiz-GaspĆ , S | |
700 | 1 | _aCarrasco, J L | |
700 | 1 | _aPortell, E | |
700 | 1 | _aVidal, J | |
700 | 1 | _aMuxi, A | |
700 | 1 | _aMonegal, A | |
700 | 1 | _aGuaƱabens, N | |
700 | 1 | _aPeris, P | |
773 | 0 |
_tOsteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA _gvol. 28 _gno. 9 _gp. 2707-2715 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00198-017-4090-4 _zAvailable from publisher's website |
999 |
_c27245106 _d27245106 |